Skip to content

Safety and efficacy of three-lens combined in treatment of cholecystolithiasis combined with small-diameter choledocholithiasis

Safety and efficacy of three-lens combined in treatment of cholecystolithiasis combined with small-diameter choledocholithiasis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067486
Enrollment
Unknown
Registered
2023-01-09
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholecystolithiasis combined with small-diameter choledocholithiasis

Interventions

Observation group:laparoscopic cholecystectomy(LC) +laparoscopic common bile duct exploration(LCBDE)+primary duct closure (PDC)+ endoscopic nasobiliary drainage(ENBD)
control group:laparoscopic cholecystectomy(LC)+ endoscopic retrograde cholangioancreatography(ERCP)/endoscopic sphincterotomy(EST) + endoscopic nasobiliary drainage(ENBD)

Sponsors

The First Hospital of Changsha
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Patients were diagnosed by preoperative symptoms and imaging examination (abdominal B ultrasound, CT, MRCP). ? The diameter of common bile duct =0.8cm. ? Age of 18-60 years old, both sexes. ? no biliary stricture, malformation or tumor. ? no hepatolithiasis, cholangitis, acute pancreatitis, Mirrizzi syndrome. ? patients undergoing elective surgery. ? Informed consent was obtained and signed.

Exclusion criteria

Exclusion criteria: ? Severe complications or rapid progression of the disease requiring emergency surgery. ? abnormal heart, brain, lung, kidney function, poor general condition, can not tolerate surgery. ? poor function or stenosis of duodenal papilla. ?history of biliary tract surgery or abdominal surgery. ? Unable to follow up or lost follow-up. ? patients with mental illness. ? Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
total bilirubin;direct bilirubin;alanine aminotransferase;aspartate aminotransferase;serum amylase;operation success rate;stone clearance rate;operation time;intraoperative blood loss;postoperative gastrointestinal function recovery time;postoperative hospital stay;postoperative complications;hospitalization cost;

Countries

China

Contacts

Public ContactJiaojiao Xu

The First Hospital of Changsha

1920214254@qq.com18394488228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026